News Tips for Sunday, Nov. 7

From the American Heart Association's 72nd Scientific Sessions
Nov. 7-10, 1999, Georgia World Congress Center, Atlanta, Georgia

To complement our news releases, here are additional news tips reported by News Media Relations from more than 4,000 abstracts. Abstract numbers are listed for each tip. Note: Stories are embargoed until papers are presented or poster sessions begin. For more information, Nov. 7-10, call Carole Bullock, Darcy Spitz, Karen Hunter, Bruce Lewis (broadcast), or Berna Diehl in the News Media Center (room 256-257W) of the Georgia World Congress Center: (404) 222-5002. Before or after those dates, call News Media Relations in Dallas: (214) 706-1279 or 706-1173.

3:45 p.m. - 176 - Trend toward better recovery with abciximab treatment within 24 hours of stroke. Giving patients the clot-busting drug abciximab within 24 hours of the onset of stroke symptoms leads to an improvement in the patient's condition and survival rate, a new study finds. Researchers say their "promising" results need confirmation in a larger study, but that the research seems to indicate even better results for patients who were studied for an additional three-months. Harold Adams, ph.: (319) 356-4110; fax: (319) 356-4505; [email protected]., University of Iowa.

4:30 p.m. - 152 - At-home care means higher survival rates, better quality of life and lower costs for heart failure patients. Researchers say that patients with congestive heart failure (CHF) in a nurse-mediated, home-based intervention program had fewer hospital admissions, longer survival rates, fewer health-care costs and a better quality of life than patients receiving conventional treatment in a hospital. In a study of 200 individuals with CHF, half received the treatment in a hospital and half received home-based intervention. After six-months, the hospital group had 129 re-admissions to the hospital or out-of-hospital deaths. The home-based intervention group had 77 hospital admissions. Also at six months, 51 patients in the home care group were healthy, compared with 38 in the hospital care group. Hospital costs for the home-care group were half that of the patients in conventional care. In a sub-group of 68 patients at a three-month follow-up, those in home-based care reported greater improvement in quality of life than did the conventional care patients. Simon Stewart, University of Glasgow, Glasgow, U.K., ph.: 44-141-330-6588; fax: 44-141-330-6588; [email protected].

###